PFIZER INC Effective Income Tax Rate Reconciliation, Tax Contingency, Percent
PFIZER INC (PFE) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Percent of 2.40% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies · last filed 2026-02-26
- PFIZER INC effective income tax rate reconciliation, tax contingency, percent for fiscal 2025 was 2.40%.
- PFIZER INC effective income tax rate reconciliation, tax contingency, percent for fiscal 2013 was -5.70%.
- PFIZER INC effective income tax rate reconciliation, tax contingency, percent for fiscal 2012 was -12.80%.
- PFIZER INC effective income tax rate reconciliation, tax contingency, percent for fiscal 2011 was -3.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 2.40% 10-K · filed 2026-02-26 | |
| 2013-12-31 | -5.70% 10-K · filed 2014-02-28 | |
| 2012-12-31 | -12.80% 10-K · filed 2014-02-28 | -12.00% 10-K · filed 2013-02-28 |
| 2011-12-31 | -3.00% 10-K · filed 2014-02-28 | -2.70% 10-K · filed 2012-02-28 |
| 2010-12-31 | -26.30% 10-K · filed 2013-02-28 | -26.40% 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |